|
Status |
Public on Aug 09, 2019 |
Title |
Expression profiling in Prostate cancer cells treated with DOT1L inhibitor |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
We performed expression profiling of prostate cancer cells, LNCaP and PC3 cells that were treated with the specific DOT1L inhibitor EPZ004777 (1uM) for 8 days. We found that unique genes were differentially expressed in both cell lines.
|
|
|
Overall design |
Examination of expression changes upon EPZ004777 treatment
|
|
|
Contributor(s) |
Abdulkadir S, Vatapalli R |
Citation(s) |
32814769 |
Submission date |
Aug 08, 2019 |
Last update date |
May 19, 2021 |
Contact name |
Rajita Vatapalli |
E-mail(s) |
rajitavatapalli2013@u.northwestern.edu
|
Phone |
3125035031
|
Organization name |
Northwestern University
|
Lab |
Abdulkadir Lab
|
Street address |
303 E SUPERIOR, 6-250
|
City |
CHICAGO |
State/province |
IL |
ZIP/Postal code |
60611 |
Country |
USA |
|
|
Platforms (1) |
GPL17586 |
[HTA-2_0] Affymetrix Human Transcriptome Array 2.0 [transcript (gene) version] |
|
Samples (12)
|
|
This SubSeries is part of SuperSeries: |
GSE135575 |
Expression profiling and H3K79me2 ChIP-seq in Prostate cancer cells treated with DOT1L inhibitor |
|
Relations |
BioProject |
PRJNA559347 |